GIS

General Mills delivered a soft Q3 FY2026 that landed near consensus expectations, but the real story is management's conviction that the worst is behind them. The company reported results weighed down by deliberate reinvestment in brand remarkability, retailer inventory headwinds, and supply chain disruptions, all of which management frames as temporary and largely one-time. The critical claim is that by the end of Q4, most of the pricing and reinvestment phase will be complete, positioning the company for a meaningful step-up in both top-line and bottom-line performance in fiscal 2027. This narrative hinges on three interconnected bets: first, that household penetration and baseline volume stabilization are genuine leading indicators of future growth; second, that the company's innovation pipeline (tracking at 25% growth, with some categories exceeding that) will drive dollar-share gains once pricing laps; and third, that the $750M transformation savings target for FY2027 will materialize and provide margin leverage as volumes stabilize. Management reaffirmed full-year FY2026 guidance and signaled confidence in the FY2027 $3.00, $3.20 EPS range, though they explicitly declined to provide 2027 specifics until June, citing macro volatility. The Brazil divestiture announced yesterday is consistent with the company's portfolio-shaping discipline over the past several years and will modestly improve International margins by shifting focus to higher-margin global platforms. On the margin front, management acknowledged Q3 gross margins were pressured but tied recovery to volume stabilization and the transformation initiative; they stopped short of committing to a specific 2027 gross margin target, instead emphasizing the path to improvement. The consumer backdrop remains stressed, management noted promotional intensity is elevated even if depth and frequency are not, but they view this as cyclical rather than structural. The key watch for investors is whether Q4 delivers the promised inflection and whether FY2027 organic sales can return to growth, even modest growth, as the company laps pricing and the innovation and marketing investments begin to compound.